Epoprostenol for Injection in Pulmonary Arterial Hypertension - Extension of AC-066A401
NCT01105117
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
2
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG:
ACT-385781A (Actelion Epoprostenol)
DRUG:
Flolan®
Sponsor
Actelion